Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and Hospitalizations

Analyze the Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and Hospitalizations Among Patients With Uncontrolled Asthma Receiving High Dose Inhaled Corticosteroids

A retrospective database analysis to evaluate the impact of omalizumab on the use of corticosteroid, emergency-department visits and hospitalizations among patients with uncontrolled asthma and using high-dose Inhaled Corticosteroids (ICS) prior to initiating omalizumab.

Inclusion Criteria:

• ≥12 years of age with a documented Cystic fibrosis (CF) diagnosis,
• on Long acting Beta antagonist- Inhaled Corticosteroid (LABA-ICS) at baseline,
• uncontrolled asthma at baseline.

Exclusion Criteria:

Other protocol-defined inclusion/exclusion criteria may apply.